Dogwood Therapeutics, Inc. (DWTX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$15.62M | -77.7% |
| 2024 | -$8.79M | -80.5% |
| 2023 | -$4.87M | +57.5% |
| 2022 | -$11.47M | +26.9% |
| 2021 | -$15.69M | -302.8% |
| 2020 | -$3.90M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$15.62M | -77.7% |
| 2024 | -$8.79M | -80.5% |
| 2023 | -$4.87M | +57.5% |
| 2022 | -$11.47M | +26.9% |
| 2021 | -$15.69M | -302.8% |
| 2020 | -$3.90M | — |